---
layout: post
title: The Clinical Kinome in 2013
date: '2013-09-22T09:26:00.001+01:00'
author: John Overington
tags:
- Kinase inhibitor
modified_time: '2013-09-22T10:19:09.864+01:00'
thumbnail: http://4.bp.blogspot.com/-8Fz_AGemwL8/Uj6pEHVTsrI/AAAAAAAADIQ/I-qgSGv0Tzk/s72-c/clinical-kinome.jpg
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-5701677206444483610
blogger_orig_url: http://chembl.blogspot.com/2013/09/the-clinical-kinome-in-2013.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://4.bp.blogspot.com/-8Fz_AGemwL8/Uj6pEHVTsrI/AAAAAAAADIQ/I-qgSGv0Tzk/s1600/clinical-kinome.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="320" src="http://4.bp.blogspot.com/-8Fz_AGemwL8/Uj6pEHVTsrI/AAAAAAAADIQ/I-qgSGv0Tzk/s320/clinical-kinome.jpg" width="278" /></a></div>
<br />
As part of a series of posts on the state of kinase inhibitors in formal clinical development, above is a mapping of the kinases for which there are potential drugs in trials. The figure was prepared by our collaborators&nbsp;<span style="font-family: inherit;">Prson Gautam and Krister Winnerberg at <a href="http://www.fimm.fi/">FIMM</a>, from the data in ChEMBL.</span>